DURECT -Durect (DRRX) Reports Q3 Loss, Misses Revenue Estimates

Durect (DRRX) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of$ 0.17. This compares to loss of $0.40 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 17.65%. A quarter ago, it was expected that this specialty pharmaceutical company would post a loss of$ 0.17 per share when it actually produced a loss of $0.12, delivering a surprise of 29.41%.Over the last four quarters, the comp ...